Ivabradine as a stabilising anti-arrhythmic agent for multifocal atrial tachycardia. (June 2020)

• Record Type: Journal Article
• Authors: Cohen, Mitchell I.; Cohen, Jordan A.; Shope, Connor; Stollar, Lauren; Collazo, Lucas
• Is Part Of: Cardiology in the young. Volume 30:Number 6(2020)
• Page Start: 899
• Page End: 902
• Publication Date: 2020-06
• Subjects: Ivabradine, -- chaotic atrial tachycardia, -- ablation, -- ECMO, -- multifocal atrial tachycardia; Pediatric cardiology -- Periodicals; 618.9212
• DOI: 10.1017/S1047951120001195
• Languages: English
• ISSNs: 1047-9511

Abstract

Abstract: Multifocal atrial tachycardia has certain electrocardiographic similarities to atrial fibrillation. The mechanism of atrial fibrillation is heterogenous but in some cases may arise from a single ectopic driver with fibrillatory conduction to the rest of the atria. This has led to the speculation that multifocal atrial tachycardia may have a similar mechanistic unifocal site that disperses through the atrium in a fibrillatory pattern. Ivabradine has been reported to be efficacious in an adult with paroxysmal atrial fibrillation as well as in children with junctional or ectopic atrial tachycardias. This is the first report of successfully using ivabradine, a novel anti-arrhythmic If blocking agent, to convert multifocal atrial tachycardia in a 5-month-old critically ill infant to a pattern indicating a single ectopic atrial focus. This allowed the patient's single atrial focus to be ablated with return to sinus rhythm and decannulation from ventriculoarterial extracorporeal membrane oxygenation. This case suggests that multifocal atrial tachycardia may arise from a single automatic focus with downstream fibrillatory conduction to the atria.